Total Funding
17
Total FundingSeed raised
Growth Score
pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
598215
Altermune Technologies develops therapeutics to combat resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza.
Kary Banks Mullis: Founder & Chief Scientific Advisor
About the Company
Altermune Technologies LLC, a newly formed company focused on the development of novel therapeutics to combat resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza.
The company is led by a team of in-house scientists, and a wide network of partnerships, including collaborative research arrangements with a number of
universities in the USA and Europe and corporate relationships with companies in oligonucleotide synthesis and aptamer selection.
